These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1207 related items for PubMed ID: 17145223
1. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S, Warfield KT, Wood CM, Miller WL. Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223 [Abstract] [Full Text] [Related]
3. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group. J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636 [Abstract] [Full Text] [Related]
4. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM, Crouch MA, Carroll NV, Oinonen MJ. Pharmacotherapy; 2006 Aug 05; 26(8):1078-85. PubMed ID: 16863484 [Abstract] [Full Text] [Related]
5. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J, Yancy CW, Fonarow GC. Am Heart J; 2007 Aug 05; 154(2):267-77. PubMed ID: 17643575 [Abstract] [Full Text] [Related]
8. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P. Am Heart J; 2007 Jun 05; 153(6):932-40. PubMed ID: 17540193 [Abstract] [Full Text] [Related]
15. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure. Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S. J Cardiovasc Pharmacol Ther; 2007 Sep 05; 12(3):232-6. PubMed ID: 17875951 [Abstract] [Full Text] [Related]
16. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R, FUSION II Investigators. Circ Heart Fail; 2008 May 05; 1(1):9-16. PubMed ID: 19808265 [Abstract] [Full Text] [Related]
19. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction. Kelesidis I, Mazurek J, Khullar P, Saeed W, Vittorio T, Zolty R. Congest Heart Fail; 2012 May 05; 18(3):158-64. PubMed ID: 22497779 [Abstract] [Full Text] [Related]